Tibet Duo Rui Pharmaceutical Co.,Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 400.98 million compared to CNY 529.62 million a year ago. Revenue was CNY 401.05 million compared to CNY 529.62 million a year ago.

Net income was CNY 20.5 million compared to CNY 68.51 million a year ago. Basic earnings per share from continuing operations was CNY 0.26 compared to CNY 1.05 a year ago. Diluted earnings per share from continuing operations was CNY 0.26 compared to CNY 1.05 a year ago.